During embryonic life, the development of a proper mass of mature pancreatic tissue is thought to require the proliferation of precursor cells, followed by their differentiation into endocrine or acinar cells. We investigated whether perturbing the proliferation of precursor cells in vitro could modify the final mass of endocrine tissue that develops. For that purpose, we used activators or inhibitors of signals mediated by receptor tyrosine kinases. We demonstrated that when embryonic day 13.5 rat pancreatic epithelium is cultured in the presence of PD98059, an inhibitor of the mitogen-activated protein (MAP) kinase, epithelial cell proliferation is decreased, whereas endocrine cell differentiation is activated. On the other hand, in the presence of epidermal growth factor (EGF), an activator of the MAP kinase pathway, the mass of tissue that develops is increased, whereas the absolute number of endocrine cells that develops is decreased. P roliferation of precursor cells and their differentiation into mature cells represent two crucial processes for the proper development of an organ. The pancreatic gland develops from the gut endodermal epithelium. It is thought that such epithelial precursor cells will first proliferate and then differentiate into endocrine cells forming the islets of Langerhans and exocrine pancreatic tissue. Although progress has recently been made concerning the transcription factors implicated in pancreatic development (1), the control of pancreatic cell growth and differentiation by growth factors remains poorly understood. The goal of the present work was to determine whether by perturbing the proliferation of pancreatic precursor cells, the final mass of endocrine cells that develop could be modified, with the objective of defining new strategies for increasing the final -cell mass.It has been proposed that ligands of receptor tyrosine kinases that are implicated in the control of cell proliferation and differentiation in a large number of organs (2) could also control pancreatic development (3,4). However, the exact function of such ligands of receptor tyrosine kinases during pancreatic development is not well established. It has recently been shown that in mice deficient in epidermal growth factor receptor (EGFR), a member of the receptor tyrosine kinase family, pancreatic cell development was abnormal (5). However, the way by which signals mediated by EGFR control the final -cell mass that develops was not elucidated. Theoretically, ligands of EGFR could control the proliferation of precursor cells, their ability to differentiate into mature cells, the level of proliferation of such mature cells, and, finally, cell survival.Recently we developed and characterized an in vitro model of pancreatic development (6,7) that allowed for testing the effects of specific growth factors on the development of the endocrine pancreas (8,9). In the present study, we used this experimental system to further study the implication of cell proliferation in the control of endocrine cell differentiati...